Cancer will have no place to hide... Affinity BIO is about to revolutionize the field of immuno-oncology by enabling antibody-based therapies to attack targets that are inside cells such as mutated cancer-causing and viral proteins. Proteins inside cells are routinely broken down into peptides which are displayed on the cell surface by Major Histocompatibility Complex (MHC), the targets of T-Cells. Affinity’s protein-display system can discover antibodies against difficult to hit targets such as peptide-MHC complexes. This ability increases the number of addressable cancer or viral targets by a factor of ten. Based on fully-human sequences, discovered antibodies can be formatted to fit any purpose, from targeting CAR-T cells, antibody-drug conjugates, bispecifics or traditional antibodies. Affinity’s discovery platform can generate high affinity (low nM/pM) and highly selective scFv (antibody fragments) in a matter of days, allowing for rapid evaluation and optimization of product candidates. Affinity is seeking partnerships to fully exploit the potential of its technology whilst also building an in-house portfolio of products.
View Top Employees from Affinity BioWebsite | http://www.affinitybio.com.au |
Revenue | $1 million |
Employees | 13 (13 on RocketReach) |
Founded | 2009 |
Address | cluster 1 dalmore Dr, Scoresby, Victoria 3179, AU |
Phone | +61 3 9763 5445 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Business Services General, Business Services |
Web Rank | 30 Million |
Keywords | Affinity Bio |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies |
Looking for a particular Affinity Bio employee's phone or email?
The Affinity Bio annual revenue was $1 million in 2024.
Kevin Beasley is the Chairman of Affinity Bio.
13 people are employed at Affinity Bio.
Affinity Bio is based in Scoresby, Victoria.
The NAICS codes for Affinity Bio are [5417, 541, 54].
The SIC codes for Affinity Bio are [28, 283].